281 related articles for article (PubMed ID: 20063079)
1. One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty.
Ralley FE; Berta D; Binns V; Howard J; Naudie DD
Clin Orthop Relat Res; 2010 Jul; 468(7):1905-11. PubMed ID: 20063079
[TBL] [Abstract][Full Text] [Related]
2. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
3. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty.
Tuttle JR; Ritterman SA; Cassidy DB; Anazonwu WA; Froehlich JA; Rubin LE
J Arthroplasty; 2014 Aug; 29(8):1512-5. PubMed ID: 24630599
[TBL] [Abstract][Full Text] [Related]
4. One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.
Wilde JM; Copp SN; McCauley JC; Bugbee WD
J Bone Joint Surg Am; 2018 Jul; 100(13):1104-1109. PubMed ID: 29975264
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty.
Gillette BP; Maradit Kremers H; Duncan CM; Smith HM; Trousdale RT; Pagnano MW; Sierra RJ
J Arthroplasty; 2013 Sep; 28(8 Suppl):137-9. PubMed ID: 23886409
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological reduction of bleeding during hip endoprosthetic replacement].
de Jonge T
Orv Hetil; 2012 Oct; 153(41):1607-12. PubMed ID: 23045310
[TBL] [Abstract][Full Text] [Related]
7. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tranexamic Acid on Transfusion Rates Following Total Joint Arthroplasty: A Cost and Comparative Effectiveness Analysis.
Evangelista PJ; Aversano MW; Koli E; Hutzler L; Inneh I; Bosco J; Iorio R
Orthop Clin North Am; 2017 Apr; 48(2):109-115. PubMed ID: 28336035
[TBL] [Abstract][Full Text] [Related]
10. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
[TBL] [Abstract][Full Text] [Related]
11. Comparing Cost, Efficacy, and Safety of Intravenous and Topical Tranexamic Acid in Total Hip and Knee Arthroplasty.
DiBlasi JF; Smith RP; Garavaglia J; Quedado J; Frye BM; Dietz MJ
Am J Orthop (Belle Mead NJ); 2016; 45(7):E439-E443. PubMed ID: 28005108
[TBL] [Abstract][Full Text] [Related]
12. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties.
Ido K; Neo M; Asada Y; Kondo K; Morita T; Sakamoto T; Hayashi R; Kuriyama S
Arch Orthop Trauma Surg; 2000; 120(9):518-20. PubMed ID: 11011672
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic Acid in Hip and Knee Arthroplasty.
Melvin JS; Stryker LS; Sierra RJ
J Am Acad Orthop Surg; 2015 Dec; 23(12):732-40. PubMed ID: 26493971
[TBL] [Abstract][Full Text] [Related]
14. Universal tranexamic acid therapy to minimize transfusion for major joint arthroplasty: a retrospective analysis of protocol implementation.
Baker JE; Pavenski K; Pirani RA; White A; Kataoka M; Waddell JP; Ho A; Schemitsch EH; Lo N; Bogoch ER; Pronovost A; Luke K; Howell A; Nassis A; Tsui AK; Tanzini RM; Pulendrarajah R; Mazer CD; Freedman J; Hare GM
Can J Anaesth; 2015 Nov; 62(11):1179-87. PubMed ID: 26335903
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oral compared with intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: a meta-analysis.
Han X; Gong G; Han N; Liu M
BMC Musculoskelet Disord; 2018 Dec; 19(1):430. PubMed ID: 30509227
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of use of tranexamic Acid to prevent major bleeding complications in hip and knee arthroplasty surgery.
Slover J; Bosco J
Am J Orthop (Belle Mead NJ); 2014 Oct; 43(10):E217-20. PubMed ID: 25303447
[TBL] [Abstract][Full Text] [Related]
17. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
[TBL] [Abstract][Full Text] [Related]
18. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012.
Moskal JT; Harris RN; Capps SG
J Arthroplasty; 2015 Mar; 30(3):365-8. PubMed ID: 25458093
[TBL] [Abstract][Full Text] [Related]
19. The routine use of tranexamic acid in hip and knee replacements.
Panchmatia JR; Chegini S; Lobban C; Shah G; Stapleton C; Smallman JM; Kucheria R
Bull NYU Hosp Jt Dis; 2012; 70(4):246-9. PubMed ID: 23267449
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.
Xie J; Hu Q; Huang Q; Ma J; Lei Y; Pei F
Thromb Res; 2017 May; 153():28-36. PubMed ID: 28319822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
